BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Business

  Vygon Opens Turkish Subsidiary

  September 14, 2015

   · 

  4 min read
• Deals

  Shire Mulls Ways to Sweeten Bid for Baxalta, Getting Cash to Baxalta Shareholders Faster

  September 14, 2015

   · 

  1 min read
• Deals

  Bay Area Depomed Rejects Horizon Pharma’s Latest Takeover Offer

  September 14, 2015

   · 

  19 min read
• Drug Development

  Raptor’s Phase IIb CyNCh Study Fails To Meet Primary Endpoint, Shares Skid

  September 14, 2015

   · 

  8 min read
• Business

  Dr. Reddy’s Laboratories Ltd. Snags Exclusive Rights to Head Lice Product From Hatchtech

  September 14, 2015

   · 

  4 min read
• Policy

  FDA Panel Gives Green Light to Collegium’s Painkiller Xtampza ER

  September 14, 2015

   · 

  5 min read
• Deals

  Mylan Takes $27.3B Buyout Offer Directly to Perrigo Shareholders

  September 14, 2015

   · 

  17 min read
• Drug Development

  Sanofi Plans LixiLan Filings After Meeting Phase III Primary Endpoint

  September 14, 2015

   · 

  8 min read
• Deals

  Cambridge’s Dimension Therapeutics Preps for $115 Million IPO

  September 14, 2015

   · 

  1 min read
• Pharm Country

  Connecticut Bioscience Innovation Fund Invests $10 Million In Program In Innovative Therapeutics For Connecticut’s Health (PITCH)

  September 14, 2015

   · 

  4 min read